The multiyear effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...

Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...

Merck KGaA Q1 Results Rise; Cuts FY25 Outlook May 15, 2025 — 01:20 am EDT Written by RTTNews.com for RTTNews -> ...

By Helena Smolak Germany's Merck KGaA slashed its full-year outlook on the back of challenging macroeconomic conditions and foreign-exchange headwinds. The life-sciences and electronics company ...

Photo: ralph orlowski/Reuters Germany’s Merck MRK -0.86% KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds.

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...

Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% ...

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

Germany’s Merck KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds. In European morning trading shares ...